Crystaline form of 1'-<(1-methylethyl)-4'-[(2-fluoro-4-methoxyphenyl)methyl]-5'-methyl-1H-pyrazol-3'-O-ß-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments

The invention relates to a crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O- -D-glucopyranoside, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	ADELGOSS, GEBBHARD, MAIER, STEFFEN, RITTER, REGINE, EICKELMANN, PETER, PINNETTI, SABINE, DURBAN, ADIL, DUGI, KLAUS, SCHILCHER, GEBHARD, THOMAS, LEO, KRAEMER, GERD, MARTIN, HANS-JUERGEN, STREICHER, RUEDIGER
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS SUGARS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The invention relates to a crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O- -D-glucopyranoside, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments.